Cetera Investment Advisers’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.34M | Sell |
48,015
-9,904
| -17% | -$482K | ﹤0.01% | 1727 |
|
|
2025
Q1 | $1.97M | Buy |
57,919
+28,084
| +94% | +$956K | ﹤0.01% | 1758 |
|
|
2024
Q4 | $1.17M | Sell |
29,835
-5,777
| -16% | -$227K | ﹤0.01% | 2056 |
|
|
2024
Q3 | $1.67M | Buy |
35,612
+8,774
| +33% | +$412K | ﹤0.01% | 1755 |
|
|
2024
Q2 | $1.45M | Sell |
26,838
-7,262
| -21% | -$392K | ﹤0.01% | 1808 |
|
|
2024
Q1 | $2.32M | Buy |
34,100
+27,915
| +451% | +$1.9M | 0.01% | 1437 |
|
|
2023
Q4 | $387K | Buy |
6,185
+440
| +8% | +$27.5K | ﹤0.01% | 1634 |
|
|
2023
Q3 | $261K | Buy |
5,745
+38
| +0.7% | +$1.73K | ﹤0.01% | 1823 |
|
|
2023
Q2 | $320K | Sell |
5,707
-2,519
| -31% | -$141K | ﹤0.01% | 1702 |
|
|
2023
Q1 | $372K | Sell |
8,226
-374
| -4% | -$16.9K | ﹤0.01% | 1580 |
|
|
2022
Q4 | $350K | Buy |
8,600
+1,957
| +29% | +$79.6K | ﹤0.01% | 1563 |
|
|
2022
Q3 | $434K | Sell |
6,643
-1,421
| -18% | -$92.8K | 0.01% | 1045 |
|
|
2022
Q2 | $490K | Buy |
8,064
+237
| +3% | +$14.4K | 0.01% | 1108 |
|
|
2022
Q1 | $491K | Buy |
7,827
+863
| +12% | +$54.1K | 0.01% | 1169 |
|
|
2021
Q4 | $528K | Sell |
6,964
-253
| -4% | -$19.2K | 0.01% | 1150 |
|
|
2021
Q3 | $808K | Buy |
7,217
+809
| +13% | +$90.6K | 0.01% | 861 |
|
|
2021
Q2 | $1.04M | Buy |
6,408
+1,786
| +39% | +$289K | 0.02% | 757 |
|
|
2021
Q1 | $563K | Sell |
4,622
-489
| -10% | -$59.6K | 0.01% | 908 |
|
|
2020
Q4 | $783K | Buy |
+5,111
| New | +$783K | 0.02% | 766 |
|